This inventor holds 4 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Seiyaku Co., Ltd.. Active years: 1991-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2002
Title: Katsuichi Sakano: Innovator in Pharmaceutical Science
Introduction
Katsuichi Sakano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that enhance the effects of insulin-like growth factors. With a total of 4 patents to his name, Sakano's work has the potential to impact various medical conditions.
Latest Patents
Sakano's latest patents include a composition of an endogenous insulin-like growth factor-II derivative. This innovation focuses on the effects of endogenous insulin-like growth factor, which can be enhanced by administering compounds that increase free IGF in living bodies. The compounds described in this patent can elevate the concentration of unbound IGF by converting endogenous IGF into free, biologically active IGF or by increasing the concentration of the IGF and IGFBP complex. These medicaments can be utilized in the prevention and treatment of IGF-responsive diseases such as diabetes, amyotrophic lateral sclerosis, and osteoporosis. Another notable patent involves optically active pyridobenzoxazine derivatives and their intermediates. This invention highlights a process for preparing optically active pyridobenzoxazine derivatives that possess increased antimicrobial activity and reduced toxicity.
Career Highlights
Throughout his career, Katsuichi Sakano has worked with esteemed companies such as Daiichi Pharmaceutical Co., Ltd. and Daiichi Seiyaku Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Sakano has collaborated with notable individuals in his field, including Nobuyuki Higashihashi and Isao Hayakawa. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Katsuichi Sakano is a distinguished inventor whose work in pharmaceutical science has led to significant advancements in the understanding and application of insulin-like growth factors. His contributions continue to pave the way for innovative treatments for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile